Eledon announces tegoprubart use in transplant of pig kidney into human
Eledon Pharmaceuticals (ELDN) announced that tegoprubart, the company’s investigational anti-CD40L antibody, was used as a key component of the ...
Earnings call transcript: Iterum Therapeutics reports Q4 2024 results and stock surges
Iterum Therapeutics PLC (NASDAQ:ITRM) reported its fourth-quarter 2024 financial results, revealing a narrower-than-expected loss. The company posted an actual EPS of -0.12, beating the forecasted EPS ...